Shovanlal Gayen Selected Research

Shovanlal Gayen Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 12/2003
7	COVID-19 02/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 11/2022 - 10/2018
2	Severe Acute Respiratory Syndrome 08/2021 - 01/2020
2	Malaria 01/2020 - 05/2011
2	Atherosclerosis 01/2019 - 02/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 10/2006
1	Shock 01/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2023
1	Toxic Optic Neuropathy 06/2023
1	Carcinoma (Carcinomatosis) 01/2022
1	Trypanosomiasis 01/2020
1	Common Cold 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Leishmaniasis 01/2020
1	Obesity 01/2019
1	Insulin Resistance 01/2019
1	Rheumatoid Arthritis 02/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2018
1	Asthma (Bronchial Asthma) 02/2018
1	Multiple Sclerosis 02/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Retinal Neovascularization 11/2017
1	Huntington Disease (Huntington's Disease) 12/2016
1	Dengue (Dengue Fever) 05/2013

Drug/Important Bio-Agent (IBA)

9	Peptide Hydrolases (Proteases)FDA Link 11/2022 - 05/2013
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2004
3	EnzymesIBA 10/2023 - 04/2020
3	PapainIBA 02/2022 - 01/2021
1	Histone Deacetylase InhibitorsIBA 04/2024
1	Viral ProteinsIBA 01/2024
1	PCI 34051IBA 10/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2023
1	CationsIBA 06/2023
1	Sulfanilamide FDA Link 06/2023
1	Topiramate (Topamax)FDA LinkGeneric 06/2023
1	Bortezomib (Velcade)FDA Link 06/2023
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 06/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2023
1	tosufloxacinIBA 06/2023
1	Choline KinaseIBA 12/2022
1	Lysine (L-Lysine)FDA Link 12/2022
1	Protein Kinases (Protein Kinase)IBA 12/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2022
1	Aurora KinasesIBA 12/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022
1	TankyrasesIBA 12/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2022
1	multidrug resistance-associated protein 1IBA 11/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	MicrocystinsIBA 01/2022
1	Coronavirus Protease InhibitorsIBA 08/2021
1	LigandsIBA 05/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2021
1	Chalcone (Benzalacetophenone)IBA 01/2020
1	Chemokine ReceptorsIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	2-phenylindoleIBA 10/2018
1	IntegrinsIBA 02/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	IndolesIBA 11/2017
1	Angiogenesis InhibitorsIBA 11/2017
1	Huntingtin ProteinIBA 12/2016
1	KynurenineIBA 12/2016
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2016
1	Tumor Suppressor Protein p53IBA 01/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2006
1	AmidesIBA 03/2004
1	Glutamine (L-Glutamine)FDA Link 03/2004
1	purineIBA 03/2004
1	NitrogenIBA 03/2004
1	Glutamic Acid (Glutamate)FDA Link 03/2004
1	Essential Amino AcidsIBA 03/2004
1	Nucleic AcidsIBA 03/2004
1	pyrimidineIBA 03/2004
1	Antineoplastic Agents (Antineoplastics)IBA 12/2003
1	pyridoacridineIBA 12/2003
1	HydrogenIBA 12/2003
1	ascidideminIBA 12/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2022
1	Immunotherapy 04/2020